What is the current valuation of the UK viscosupplementation market in 2024?

The overall market valuation was $117.09 Million in 2024. Read More

What is the projected market valuation for the UK viscosupplementation market by 2035?

The projected valuation for 2035 is $330.0 Million. Read More

What is the expected CAGR for the UK viscosupplementation market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 9.88%. Read More

Which application segment holds the highest valuation in the UK viscosupplementation market?

The Osteoarthritis application segment holds a valuation range of $40.0 - $110.0 Million. Read More

What is the valuation range for the Protein-Based Products segment in the UK viscosupplementation market?

The Protein-Based Products segment has a valuation range of $25.0 - $70.0 Million. Read More

Which route of administration is projected to have the highest valuation in the UK viscosupplementation market?

The Intra-Articular Injection route is projected to have a valuation range of $70.0 - $200.0 Million. Read More

What is the valuation range for the Rehabilitation Centers end-use segment?

The Rehabilitation Centers end-use segment has a valuation range of $42.09 - $115.0 Million. Read More

How does the market for Sports Injuries compare to other application segments?

The Sports Injuries application segment has a valuation range of $20.0 - $50.0 Million, indicating a moderate market presence. Read More

What is the valuation range for Other Orthopedic Conditions in the UK viscosupplementation market?

The Other Orthopedic Conditions segment has a valuation range of $12.09 - $40.0 Million. Read More

UK Viscosupplementation Market

Q: What are the key players in the UK viscosupplementation market?

Key players include Hyaluronic Acid, Sanofi, Zimmer Biomet, MediKine, Fidia Farmaceutici, Seikagaku Corporation, Evolva Holding SA, and Stryker Corporation. Read More

ID: MRFR/HC/47660-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

UK Viscosupplementation Market Research Report By Type (Stabilized Hyaluronic Acid, Standard hyaluronic) and By Procedure (Three-Injection Procedure) - Growth & Industry Forecast 2025 To 2035

UK Viscosupplementation Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)9.88%

2024 Market Size$ 117.09 Million

2025 Market Size$ 128.66 Million

2035 Market Size$ 330 Million

Key Players

Hyaluronic Acid

Sanofi

Zimmer Biomet

MediKine

Fidia Farmaceutici

Seikagaku Corporation

Trends

Rising Demand for Non-Surgical Treatments
Technological Advancements in Product Development
Growing Patient Awareness and Education

Opportunities

Rising Healthcare Expenditure
Advancements in Injection Techniques
Increased Focus on Patient-Centric Care

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Application (USD Million)
  1. 4.1.1 Osteoarthritis
  2. 4.1.2 Rheumatoid Arthritis
  3. 4.1.3 Sports Injuries
  4. 4.1.4 Joint Surgery
  5. 4.1.5 Other Orthopedic Conditions
2. 4.2 Life Sciences, BY Product Type (USD Million)
  1. 4.2.1 Hyaluronic Acid
  2. 4.2.2 Protein-Based Products
  3. 4.2.3 Steroid Injections
  4. 4.2.4 Platelet-Rich Plasma
  5. 4.2.5 Other Viscosupplements
3. 4.3 Life Sciences, BY Route of Administration (USD Million)
  1. 4.3.1 Intra-Articular Injection
  2. 4.3.2 Intravenous Injection
  3. 4.3.3 Intrasynovial Injection
4. 4.4 Life Sciences, BY End-Use (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Clinics
  3. 4.4.3 Ambulatory Surgical Centers
  4. 4.4.4 Rehabilitation Centers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Hyaluronic Acid (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Sanofi (FR)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Zimmer Biomet (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 MediKine (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Fidia Farmaceutici (IT)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Seikagaku Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Evolva Holding SA (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stryker Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY APPLICATION
3. 6.3 UK MARKET ANALYSIS BY PRODUCT TYPE
4. 6.4 UK MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
5. 6.5 UK MARKET ANALYSIS BY END-USE
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY PRODUCT TYPE, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY END-USE, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY END-USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Life Sciences Market Segmentation

Life Sciences By Application (USD Million, 2025-2035)

Osteoarthritis
Rheumatoid Arthritis
Sports Injuries
Joint Surgery
Other Orthopedic Conditions

Life Sciences By Product Type (USD Million, 2025-2035)

Hyaluronic Acid
Protein-Based Products
Steroid Injections
Platelet-Rich Plasma
Other Viscosupplements

Life Sciences By Route of Administration (USD Million, 2025-2035)

Intra-Articular Injection
Intravenous Injection
Intrasynovial Injection

Life Sciences By End-Use (USD Million, 2025-2035)

Hospitals
Clinics
Ambulatory Surgical Centers
Rehabilitation Centers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”